Losartan vs Pembrolizumab
Losartan vs Pembrolizumab: Overview
This comparison examines the pharmacological differences between Losartan and Pembrolizumab.
Mechanism of Action
Losartan: Angiotensin II receptor type 1 antagonist.
Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.
Pharmacokinetics
Half-life: Losartan — 2 hours; Pembrolizumab — 26 days.
Chemical Properties
Molecular Formula: Losartan — C22H23ClN6O.
Molecular Weight: Losartan — 422.9200 g/mol.
Type: Losartan — Small molecule; Pembrolizumab — Antibody.